Chinese biopharma firm Akeso re-files for Hong Kong IPO

Chinese biopharma firm Akeso re-files for Hong Kong IPO

05 February, 2020

Akesobio Hong Kong Exchange (HKEx)Loyal Valley Capital Sino Biopharmaceutical Co. Ltd

Printed by Unregistered user on Tue, 29 Jul 2025 13:55:53 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Pharma companies set to raise $5b in Hong Kong IPOs this year

China's Hansoh Pharma re-files for Hong Kong IPO

Read more from Greater China

Policy & Regulations

Hong Kong may issue first stablecoin licences early next year

HK-based SC Lowy closes $250m real estate financing deal in Seoul